Emmessar Biotech & Nutrition Ltd
This is a site slogan
About VedaCeuticals
FAQs
GTranslate
Select Language
English
Afrikaans
Arabic
Bengali
Chinese (Simplified)
Chinese (Traditional)
Filipino
French
German
Gujarati
Hindi
Indonesian
Italian
Japanese
Kannada
Korean
Malay
Malayalam
Marathi
Punjabi
Russian
Sinhala
Spanish
Swahili
Swedish
Tamil
Telugu
Thai
Turkish
Urdu
Vietnamese
Zulu
Home
About Us
About EBNL
About VedaCeuticals
EBNL Leadership
Alliances & Partners
Corporate Announcements
Customer Testimonials
Products
All Categories
Skin Cure
All Skin Cure products
1st Aid Lotion
Acnea Gel
BanDruff Cream
CalmCream
CalmCream RESQ
Dermat Capsules
Dermat Ointment
Fungi-Rid Capsules
Fungi-Rid Cream
Perfect Skin Cream
Perfect Skin Syrup
PsoriBalm
Topical Treat Cream
Urtika Lotion
Skin Care
All Skin Care products
Cute-N-Comely Cream
Glide Shaving Cream
MagiCream
Skin-Glow Cream
General Health
All General Health products
BioSulf Powder
CC-99 Cough Syrup
Diabeteze Capsules
Frejomus Capsules
Gud-Helth Capsules
Gud-Hart Capsules
MSM Powder
Releef Capsules
Releef Gel
Sepecer Capsules
Tire-Not Capsules
Bone Care
Supportt-Bones Powder
Muscle Care
All Muscle Care products
Muscle Flex Capsules
Muscle Flex Gel
Pain Relief
All Pain Relief products
Supportt-Joint Powder
Vedarin Balm
Sexual Health
All Sexual Health products
ElectriQ Capsules for Men (with gold)
ElectriQ Capsules for Women (with gold)
ElectriQ Gel for Men (with gold)
ElectriQ Gel for Women (with gold)
Blogs
Investors
Fast Facts
Financials
Shareholder's Information
Announcements & Notices
Investor Queries
Contact Us
Write to Us
Our Locations
FAQ
Quick Links
All products
Skin cure
Skin care
Muscle care
Bone care
General health
Pain relief
Sexual health
Shareholder's Information
Home
Investor Relations
Shareholder's Information
Investor Relations tabs
Shareholder’s Fast Facts
Financials
Shareholder's Information
Announcements & Notices
Investor Queries
Share Holding Pattern for
FY 2022 - 23
FY 2021 - 22
FY 2020 - 21
FY 2019 - 20
FY 2018 - 19
FY 2017 - 18
FY 2016 - 17
FY 2015 - 16
FY 2014 - 15
FY 2013 - 14
FY 2012 - 13
FY 2011 - 12
FY 2010 - 11
Share Holding Pattern as on March 31, 2023.pdf
Share Holding Pattern as on December 31, 2022.pdf
Share Holding Pattern as on September 30, 2022.pdf
Share Holding Pattern as on June 30, 2022.pdf
Reconciliation of Share Capital Audit Report(s) for
FY 2022 - 23
FY 2021 - 22
FY 2020 - 21
FY 2019 - 20
FY 2018 - 19
FY 2017 - 18
FY 2016 - 17
FY 2015 - 16
FY 2014 - 15
FY 2013 - 14
FY 2012 - 13
FY 2011 - 12
FY 2010 - 11
Secretarial Audit Report for the quarter ended March 31, 2023.pdf
Secretarial Audit Report for the quarter ended December 31, 2022.pdf
Secretarial Audit Report for the quarter ended September 30, 2022.pdf
Secretarial Audit Report for quarter ended June 30, 2022.pdf
Corporate Governance Report(s) for
FY 2022 - 23
FY 2021 - 22
FY 2020 - 21
FY 2019 - 20
FY 2018 - 19
FY 2017 - 18
FY 2016 - 17
FY 2015 - 16
FY 2014 - 15
FY 2013 - 14
FY 2012 - 13
FY 2011 - 12
FY 2010 - 11
Corporate Governance Report for the quarter ended March 31, 2023.pdf
Corporate Governance Report for the quarter ended December 31, 2022.pdf
Corporate Governance Report for the quarter ended September 30, 2022.pdf
Corporate Governance Report for the Quarter ended June 30, 2022.pdf
Other Filings with Stock Exchanges for
FY 2022 - 23
FY 2021 - 22
FY 2020 - 21
FY 2019 - 20
FY 2018 - 19
FY 2017 - 18
FY 2016 - 17
FY 2015 - 16
FY 2014 - 15
FY 2013 - 14
FY 2012 - 13
FY 2011 - 12
FY 2010 - 11
Certificate UR Reg7(3) from RTA for the year ended March 31, 2023.pdf
Certificate UR 74(5) for the quarter ended March 31, 2023.pdf
SDD Certificate for the quarter ended March 31, 2023.pdf
Certificate UR 40-9 of SEBI [LODR] Regulations 2015 for the year ended March 31, 2023.pdf
SDD Certificate for the quarter ended December 31, 2022.pdf
Certificate UR Reg 74(5) for the quarter ended December 31, 2022.pdf
SDD Certificate for the quarter ended June 30, 2022.pdf
SDD Certificate for the quarter ended September 30, 2022.pdf
Certificate UR 74(5) for the quarter ended September 30, 2022.pdf
Certificate UR 74(5) for the quarter ended June 30, 2022.pdf
Postal Ballots & e-Voting Report(s) for
FY 2022 - 23
FY 2021 - 22
FY 2020 - 21
FY 2019 - 20
FY 2018 - 19
FY 2017 - 18
FY 2016 - 17
FY 2015 - 16
FY 2014 - 15
FY 2013 - 14
FY 2012 - 13
FY 2011 - 12
FY 2010 - 11
Report not available.
Other Reports for
FY 2022 - 23
FY 2021 - 22
FY 2020 - 21
FY 2019 - 20
FY 2018 - 19
FY 2017 - 18
FY 2016 - 17
FY 2015 - 16
FY 2014 - 15
FY 2013 - 14
FY 2012 - 13
FY 2011 - 12
FY 2010 - 11
Investors Grievance Report for the quarter ended March 31, 2023.pdf
Initial Disclosure - Large Corporates as on April 01, 2023.pdf
Disclosure UR 31(4) as on March 31, 2023.pdf
Disclosure UR 30(1) & 30 (2) as on March 31, 2023.pdf
Investor Grievance Report for the quarter ended December 31, 2022.pdf
List of Board Committee Members.pdf
Investors Grievance Report for the quarter ended September 30, 2022.pdf
Investors Grievance Report for the quarter ended June 30, 2022.pdf
